Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

TAMPA, Fla. (Dec. 19, 2025) — A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease ...

The landscape of metastatic prostate cancer (mPCa) treatment has evolved significantly with the advent of targeted therapies, particularly poly (ADP-ribose) polymerase inhibitors (PARPis). 1 However, ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials ASCO Guidelines provide recommendations with comprehensive ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure. This test, reported ...

Thousands of people in England will be able to check whether they have genes linked to cancer.

They include the “Jolie” gene, named after actress Angelina Jolie, who had preventative surgery after finding out she had a ...